Home Ionpath

Ionpath

In operation
Series B
Tissue Imaging Technology Developer
Basic
Enterprise Profile

Basic Information

IONpath is revolutionizing tissue imaging to accelerate medical discoveries and improve human health. The company’s MIBIscope system leverages Multiplexed Ion Beam Imaging (MIBI) technology, representing a transformative step in tissue imaging by simultaneously multiplexing over 40 markers at single-cell resolution. Leading research institutions as well as biotech and pharmaceutical companies are utilizing the MIBIscope for immunology, immuno-oncology, and neuroscience research requiring high-fidelity multiplex imaging data. In addition to the MIBIscope system, IONpath empowers R&D initiatives of academic, biotech, and pharmaceutical partners through IONpath Research Services.
Ionpath, Inc.
California,United States of America
15~50 people
January 01, 2014
partnerships@ionpath.com

Enterprise Profile

Industrial Sector
Medical Device R&D and Design # Diagnostic Manufacturing
Technology
Biotechnology Medical Imaging Technology
Concept
Tumor Imaging Diagnosis Department of Radiology
Application Scenarios
Intelligent Medical Devices Early Disease Screening